Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries

Biochemical insights from population studies with genetics and metabolomics

(2016) Karsten Suhre et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Smokescreen: a targeted genotyping array for addiction research

(2016) James W. Baurley et al.   BMC GENOMICS

Rate of Nicotine Metabolism and Smoking Cessation Outcomes in a Community-based Sample of Treatment-Seeking Smokers

(2015) Amanda Kaufmann et al.   ADDICTIVE BEHAVIORS

Genome-Wide Association Study of Nicotine Dependence in American Populations: Identification of Novel Risk Loci in Both African-Americans and European-Americans

(2015) Joel Gelernter et al.   BIOLOGICAL PSYCHIATRY

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation

(2015) J.-A. Tanner et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Integrative analysis of 111 reference human epigenomes

(2015) Anshul Kundaje et al.   NATURE

CYP2A6Longitudinal Effects in Young Smokers

(2015) Dale S. Cannon et al.   NICOTINE & TOBACCO RESEARCH

Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers

(2015) Diana A. Hamilton et al.   NICOTINE & TOBACCO RESEARCH

HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease

(2015) Lucas D. Ward et al.   NUCLEIC ACIDS RESEARCH

A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism

(2015) Anu Loukola et al.   PLoS Genetics

Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence

(2015) D B Hancock et al.   Translational Psychiatry

Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial

(2015) Caryn Lerman et al.   Lancet Respiratory Medicine

Modeling the Potential Effects of New Tobacco Products and Policies: A Dynamic Population Model for Multiple Product Use and Harm

(2015) Eric D. Vugrin et al.   PLoS One

Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption

(2015) Andrew W. Bergen et al.   PLoS One

Genome-Wide Association Identifies Regulatory Loci Associated with Distinct Local Histogram Emphysema Patterns

(2014) Peter J. Castaldi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations

(2014) Y. M. Patel et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Known and Novel Sources of Variability in the Nicotine Metabolite Ratio in a Large Sample of Treatment-Seeking Smokers

(2014) M. J. Chenoweth et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA

(2014) Ursula E Bauer et al.   LANCET

The human splicing code reveals new insights into the genetic determinants of disease

(2014) H. Y. Xiong et al.   SCIENCE

Gender, acculturation, and smoking behavior among U.S. Asian and Latino immigrants

(2014) Bridget K. Gorman et al.   SOCIAL SCIENCE & MEDICINE

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)

(2013) Li-Shiun Chen et al.   ADDICTION

Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black, and Asian Nonsmokers

(2013) D A Dempsey et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Biomarkers for Smoking Cessation

(2013) K J Bough et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genomics and personalized medicine: CHRNA5-CHRNA3-CHRNB4 and smoking cessation treatment

(2013) Li-Shiun Chen et al.   JOURNAL OF FOOD AND DRUG ANALYSIS

Cancer Incidence Trends Among Asian American Populations in the United States, 1990-2008

(2013) S. L. Gomez et al.   JNCI-Journal of the National Cancer Institute

The Genotype-Tissue Expression (GTEx) project

(2013) John Lonsdale et al.   NATURE GENETICS

Effect of Neuronal Nicotinic Acetylcholine Receptor Genes (CHRN) on Longitudinal Cigarettes per Day in Adolescents and Young Adults

(2013) D. S. Cannon et al.   NICOTINE & TOBACCO RESEARCH

Smoking-Attributable Mortality by Cause in the United States: Revising the CDC's Data and Estimates

(2012) B. Rostron   NICOTINE & TOBACCO RESEARCH

Race, Gender, and Nicotine Metabolism in Adolescent Smokers

(2012) M. L. Rubinstein et al.   NICOTINE & TOBACCO RESEARCH

PharmGKB summary

(2012) Ellen M. McDonagh et al.   Pharmacogenetics and Genomics

Haplotypes with Copy Number and Single Nucleotide Polymorphisms in CYP2A6 Locus Are Associated with Smoking Quantity in a Japanese Population

(2012) Natsuhiko Kumasaka et al.   PLoS One

Racial and regional disparities in lung cancer incidence

(2011) J. Michael Underwood et al.   CANCER

Nicotine Metabolite Ratio Predicts Smoking Topography and Carcinogen Biomarker Level

(2011) A. A. Strasser et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

ACHRNA5allele related to nicotine addiction and schizophrenia

(2011) L. E. Hong et al.   GENES BRAIN AND BEHAVIOR

Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk

(2011) Catherine A. Wassenaar et al.   JNCI-Journal of the National Cancer Institute

The Human Epigenome Browser at Washington University

(2011) Xin Zhou et al.   NATURE METHODS

The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European–Americans

(2011) Joseph Bloom et al.   Pharmacogenetics and Genomics

METAL: fast and efficient meta-analysis of genomewide association scans

(2010) C. J. Willer et al.   BIOINFORMATICS

Glucuronidation Genotypes and Nicotine Metabolic Phenotypes: Importance of Functional UGT2B10 and UGT2B17 Polymorphisms

(2010) G. Chen et al.   CANCER RESEARCH

MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes

(2010) Yun Li et al.   GENETIC EPIDEMIOLOGY

Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior

(2010) Thorgeir E Thorgeirsson et al.   NATURE GENETICS

Using a cessation-related outcome index to assess California's cessation progress at the population level

(2010) H. Tang et al.   TOBACCO CONTROL

Multiple Independent Loci at Chromosome 15q25.1 Affect Smoking Quantity: a Meta-Analysis and Comparison with Lung Cancer and COPD

(2010) Nancy L. Saccone et al.   PLoS Genetics

Genetic and environmental influences on the ratio of 3′hydroxycotinine to cotinine in plasma and urine

(2009) Gary E. Swan et al.   Pharmacogenetics and Genomics

Phase I Metabolic Genes and Risk of Lung Cancer: Multiple Polymorphisms and mRNA Expression

(2009) Melissa Rotunno et al.   PLoS One

Nicotine Metabolism in Three Ethnic/Racial Groups with Different Risks of Lung Cancer

(2008) K. S. Derby et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease

(2008) Thorgeir E. Thorgeirsson et al.   NATURE